FDA Inspection 1306492 — Gul Basaran
The FDA completed an inspection of Gul Basaran on Feb 20, 2026 in Altunizade. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Altunizade (Turkey)
Additional details
Clinical Investigator (CI)